Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.

New treatments for HIV can improve immune functioning and decrease mortality. However, lapses in adherence may render these complex regimens ineffective. Sixty-three men and 9 women on highly active antiretroviral therapy completed measures of medication adherence, psychological characteristics, and barriers to adherence. HIV viral load, a health outcome measure of virus amount present in blood, was also obtained. The sample was 36% African American and 56% Caucasian, with 35% reporting disability. Nearly one third of patients had missed medication doses in the past 5 days, and 18% had missed doses weekly over the past 3 months. Frequency of missed doses was strongly related to detectable HIV viral loads. Depression, side-effect severity, self-efficacy, and social support distinguished patients with good and poor adherence. Barriers also varied with adherence level. Implications for interventions promoting HIV treatment adherence are discussed.

[1]  L. Irwig,et al.  A randomized controlled trial of compliance improving strategies in Soweto hypertensives. , 1991, Medical care.

[2]  Ryo Oda,et al.  Société Francophone de Primatologie Francophone Primatological Society , 1992 .

[3]  F. Mostashari,et al.  Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[4]  T. Merigan,et al.  Multiple Concurrent Reverse Transcriptase and Protease Mutations and Multidrug Resistance of HIV-1 Isolates from Heavily Treated Patients , 1998, Annals of Internal Medicine.

[5]  F. Altice,et al.  The Era of Adherence to HIV Therapy , 1998, Annals of Internal Medicine.

[6]  C. Cutrona.  Ratings of social support by adolescents and adult informants: degree of correspondence and prediction of depressive symptoms. , 1989, Journal of personality and social psychology.

[7]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. , 1998, JAMA.

[8]  W. Agras.  Understanding compliance with the medical regimen: the scope of the problem and a theoretical perspective. , 1989, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[9]  Douglas D. Richman,et al.  Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel , 1996 .

[10]  J. Rabkin,et al.  Adherence: a necessity for successful HIV combination therapy. , 1999, AIDS.

[11]  W. Bailey,et al.  A randomized trial to improve self-management practices of adults with asthma. , 1990, Archives of internal medicine.

[12]  R. Haynes,et al.  WORK-SITE TREATMENT OF HYPERTENSION BY SPECIALLY TRAINED NURSES A Controlled Trial , 1979, The Lancet.

[13]  J. Kelly,et al.  IMPLICATIONS OF HIV TREATMENT ADVANCES FOR BEHAVIORAL RESEARCH ON AIDS : PROTEASE INHIBITORS AND NEW CHALLENGES IN HIV SECONDARY PREVENTION , 1998 .

[14]  Timothy W. Smith,et al.  Managing chronic illness : a biopsychosocial perspective , 1995 .

[15]  J R Ickovics,et al.  Adherence in AIDS clinical trials: a framework for clinical research and clinical care. , 1997, Journal of clinical epidemiology.

[16]  J. Kahn,et al.  Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. , 1998, The New England journal of medicine.

[17]  J. Montaner,et al.  A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study. , 1998, JAMA.

[18]  A. Wu,et al.  Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[19]  V L Yu,et al.  Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. , 1996, AIDS care.

[20]  A Nicoll,et al.  Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choice. , 1999, AIDS.

[21]  J. Rockstroh,et al.  Reply: Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. , 1997, AIDS.

[22]  U. Henriques.  [AIDS and behavior]. , 1993, Ugeskrift for laeger.

[23]  M. B. Pounds,et al.  Medical adherence among prenatal, HIV seropositive, African American women: Family issues , 1993 .

[24]  L. Burke,et al.  Clinical assessment and management of adherence to medical regimens. , 1995 .

[25]  J. S. St. Lawrence,et al.  Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with human immunodeficiency virus (HIV) infection. , 1993, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[26]  E. Morse,et al.  Determinants of subject compliance within an experimental anti-HIV drug protocol. , 1991, Social science & medicine.

[27]  S. Folkman,et al.  Coping effectiveness training for men living with HIV: Preliminary findings , 1996, International journal of STD & AIDS.

[28]  L. Radloff.  The CES-D Scale , 1977 .